Tryp Therapeutics Inc. announced that Mr. David L. Tousley, CPA, MBA, has been appointed as a new independent director to replace William Garner, M.D., who stepped down from the Tryp Board of Directors in connection with his investment in the Company's previously announced non-brokered private placement (the "Private Placement").
Tryp Therapeutics Inc. Canadian Securities Exchange
Equities
TRYP
CA89854F1062
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+46.03% | 55.66B | |
-7.53% | 38.98B | |
+37.04% | 38.8B | |
-9.38% | 27.32B | |
+12.31% | 26.29B | |
-16.38% | 20.25B | |
+30.79% | 12.76B | |
+28.57% | 12.18B | |
-0.36% | 12.12B |